Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)
阿法替尼治疗ERBB1-3基因改变的晚期尿路上皮癌患者的II期试验（LUX-Bladder 1）
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-023-02513-6
Font, Albert; Mellado, Begona; Climent, Miguel A; Virizuela, Juan Antonio; Oudard, Stephane; Puente, Javier; Castellano, Daniel; González-Del-Alba, Aranzazu; Pinto, Alvaro; Morales-Barrera, Rafael; Rodriguez-Vida, Alejo; Fernandez, Pedro L; Teixido, Cristina; Jares, Pedro; Aldecoa, Iban; Gibson, Neil; Solca, Flavio; Mondal, Shoubhik; Lorence, Robert M; Serra, Josep; Real, Francisco X
